Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation

C Main; L Bojke; S Griffin; G Norman; M Barbieri; L Mather; D Stark; S Palmer; R Riemsma

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation

C Main, L Bojke, S Griffin, G Norman, M Barbieri, L Mather, D Stark, S Palmer, R Riemsma

Research output: Contribution to journal › Literature review › peer-review

Original language	English
Pages (from-to)	1+
Number of pages	129
Journal	Health technology assessment
Volume	10
Issue number	9
Publication status	Published - Mar 2006

Cite this

@article{af6badb7808949d997edf542ef0b05ee,

title = "Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation",

author = "C Main and L Bojke and S Griffin and G Norman and M Barbieri and L Mather and D Stark and S Palmer and R Riemsma",

year = "2006",

month = mar,

language = "English",

volume = "10",

pages = "1+",

journal = "Health technology assessment",

issn = "1366-5278",

publisher = "NIHR Journals Library",

number = "9",

}

TY - JOUR

T1 - Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation

AU - Main, C

AU - Bojke, L

AU - Griffin, S

AU - Norman, G

AU - Barbieri, M

AU - Mather, L

AU - Stark, D

AU - Palmer, S

AU - Riemsma, R

PY - 2006/3

Y1 - 2006/3

M3 - Literature review

SN - 1366-5278

VL - 10

SP - 1+

JO - Health technology assessment

JF - Health technology assessment

IS - 9

ER -